WO1999006838A3 - Novel method of detecting amyloid-like fibrils or protein aggregates - Google Patents

Novel method of detecting amyloid-like fibrils or protein aggregates Download PDF

Info

Publication number
WO1999006838A3
WO1999006838A3 PCT/EP1998/004810 EP9804810W WO9906838A3 WO 1999006838 A3 WO1999006838 A3 WO 1999006838A3 EP 9804810 W EP9804810 W EP 9804810W WO 9906838 A3 WO9906838 A3 WO 9906838A3
Authority
WO
WIPO (PCT)
Prior art keywords
fibrils
protein aggregates
disease
novel method
aggregates
Prior art date
Application number
PCT/EP1998/004810
Other languages
French (fr)
Other versions
WO1999006838A2 (en
Inventor
Erich Wanker
Hans Lehrach
Eberhard Scherzinger
Gillian Bates
Original Assignee
Max Planck Gesellschaft
Erich Wanker
Hans Lehrach
Eberhard Scherzinger
Gillian Bates
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft, Erich Wanker, Hans Lehrach, Eberhard Scherzinger, Gillian Bates filed Critical Max Planck Gesellschaft
Priority to US09/485,005 priority Critical patent/US7595199B1/en
Priority to DE69834193T priority patent/DE69834193T2/en
Priority to EP98943817A priority patent/EP1005654B1/en
Publication of WO1999006838A2 publication Critical patent/WO1999006838A2/en
Publication of WO1999006838A3 publication Critical patent/WO1999006838A3/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The present invention relates to methods of detecting the presence of detergent- or urea-insoluble amyloid-like fibrils or protein aggregates on filters. Preferably, said fibrils or aggregates are indicative of a disease, preferably of a neurodegenerative disease such as Alzheimer's disease or Huntington's disease. In addition, the present invention relates to inhibitors identified by the method of the invention, to pharmaceutical compositions comprising said inhibitors and to diagnostic compositions useful for the investigation of said amyloid-like fibrils or aggregates.
PCT/EP1998/004810 1997-08-01 1998-07-31 Novel method of detecting amyloid-like fibrils or protein aggregates WO1999006838A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US09/485,005 US7595199B1 (en) 1998-07-31 1998-07-31 Method of detecting amyloid-like fibrils or protein aggregates
DE69834193T DE69834193T2 (en) 1997-08-01 1998-07-31 METHOD FOR DETERMINING AMYLOID-RELATED FIBRILLES OR PROTEIN AGGREGATES
EP98943817A EP1005654B1 (en) 1997-08-01 1998-07-31 Novel method of detecting amyloid-like fibrils or protein aggregates

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97113320.2 1997-08-01
EP97113320 1997-08-01

Publications (2)

Publication Number Publication Date
WO1999006838A2 WO1999006838A2 (en) 1999-02-11
WO1999006838A3 true WO1999006838A3 (en) 1999-07-08

Family

ID=8227164

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/004810 WO1999006838A2 (en) 1997-08-01 1998-07-31 Novel method of detecting amyloid-like fibrils or protein aggregates

Country Status (3)

Country Link
AT (1) ATE323288T1 (en)
DE (1) DE69834193T2 (en)
WO (1) WO1999006838A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6846640B2 (en) * 2002-04-30 2005-01-25 Pharmacia & Upjohn Company Time-resolved fluorescence assay for the detection of multimeric forms of A-beta 1-40
US10556946B2 (en) 2014-07-29 2020-02-11 Neurimmunie Holding AG Human derived anti-Huntingtin (HTT) antibodies and uses thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0206302A2 (en) * 1985-06-25 1986-12-30 Ciba-Geigy Ag New Assay and purification of amyloid components, applications, and kits therefor
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
WO1996012544A1 (en) * 1994-10-19 1996-05-02 The General Hospital Corporation A DIAGNOSTIC ASSAY FOR ALZHEIMER'S DISEASE: ASSESSMENT OF Aβ ABNORMALITIES
EP0854364A1 (en) * 1997-01-18 1998-07-22 Harash Kumar Narang Diagnosis of neuro-degenerative disorders

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0206302A2 (en) * 1985-06-25 1986-12-30 Ciba-Geigy Ag New Assay and purification of amyloid components, applications, and kits therefor
US5234814A (en) * 1989-06-01 1993-08-10 Du Pont Merck Pharmaceutical Company Diagnostic assay for alzheimer's disease
WO1996012544A1 (en) * 1994-10-19 1996-05-02 The General Hospital Corporation A DIAGNOSTIC ASSAY FOR ALZHEIMER'S DISEASE: ASSESSMENT OF Aβ ABNORMALITIES
EP0854364A1 (en) * 1997-01-18 1998-07-22 Harash Kumar Narang Diagnosis of neuro-degenerative disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TATEISHI, J. ET AL: "Removal of causative agent of Creutzfeldt-Jakob disease (CJD) through membrane filtration method.", MEMBRANE, vol. 18, no. 6, 1993, pages 357 - 362, XP002101228 *

Also Published As

Publication number Publication date
DE69834193D1 (en) 2006-05-24
DE69834193T2 (en) 2007-04-19
ATE323288T1 (en) 2006-04-15
WO1999006838A2 (en) 1999-02-11

Similar Documents

Publication Publication Date Title
WO1999006545A3 (en) Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
EP0911390A3 (en) Protein kinases as tools for the diagnosis and treatment of Alzheimer's disease
ES2170104T3 (en) INHIBITORS OF THE PRODUCTION OF BETA-AMILOID PROTEINS.
EP1308461A3 (en) Antibodies to beta-amyloids or their derivatives and use thereof
YU46097A (en) Novel class of esters and their pharmaceutical compositions
WO2005000193A3 (en) Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
DE69926254D1 (en) USE OF RADIOLIGANDS FOR SCREENING INHIBITORS OF THE PREPARATION OF BETA-AMYLOID PEPTIDES
WO2000073452A3 (en) Compositions and methods for the treatment of immune related diseases
DE59809163D1 (en) PRODUCTION OF MONO- AND 1,7-N-N-HYDROXYALKYL-CYCLEN AND LITHIUM-SALZ-COMPLEXES
WO2003007803A3 (en) Methods for diagnosing and treating alzheimer's disease and parkinson's disease
PT1214600E (en) DETERMINATION OF PROTEINS FROM LIGACAO TO ADRENOMEDULIN
DE10295664D2 (en) Method for the detection of Alzheimer's disease and to differentiate between Alzheimer's disease and other dementia diseases, associated paptids and their uses
WO2001058476A3 (en) Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity
ATE240743T1 (en) METHOD AND SUBSTANCES AGAINST PROTOZOA
WO2000034511A3 (en) Aβ-PEPTIDE SCREENING ASSAY
WO1999014241A3 (en) Compositions and methods for the treatment of immune related diseases
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
EP0716591A4 (en) METHODS AND COMPOSITIONS FOR BINDING TAU AND MAP2c PROTEINS
ID27000A (en) PROCESS FOR SEPARATION OF ENANSIOMER-ENANSIOMER 3 (R) -AND 3 (S) -HYDROCYSI-1-METHYL-4 (2,4,66-TRYMETHOPHENPHENYL) -1,2,3,6-TETRAHIDROPIRIDINE OR CARBOXICYLIC ACID ESTERS
DE69808475T2 (en) AMINO ACID DERIVATIVES FOR TREATING STROKE
WO1999006838A3 (en) Novel method of detecting amyloid-like fibrils or protein aggregates
SE9602822D0 (en) New receptor
EP0402923A3 (en) 2,5-diaminotetralines, process for their preparation and their use as medicine
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 1998943817

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998943817

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09485005

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: CA

WWG Wipo information: grant in national office

Ref document number: 1998943817

Country of ref document: EP